+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Whole Exome Sequencing Market to 2027 - Global Analysis and Forecasts by Products & Service; Technology; Applications and Geography

  • ID: 4841362
  • Report
  • Region: Global
  • 178 pages
  • The Insight Partners
1 of 3

FEATURED COMPANIES

  • Centogene AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Stratos Genomics
  • MORE
The global whole exome sequencing market is expected to reach US$ 3,812.0 Mn in 2027 from US$ 755.68 Mn in 2018. The market is estimated to grow with a CAGR of 19.8% from 2019-2027.

The market is driven by the factors such as, reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery are likely to drive the growth of the whole exome sequencing market. However, ethical, social and legal concerns for whole exome sequencing and dearth of highly skilled professionals may restrict the growth of whole exome sequencing market.

The next-generation sequencing has enabled higher results of the analysis for genotypic and phenotypic relations among the human populations, helping in the development of genetics information for the drug development. In various human diseases are caused or are influenced by the genetic factors which provide important information about the diseases and thus help in the discovery of a novel drug.

As the whole sequencing techniques reduced time and cost for the analyzing genetic, it also offers a reduction of time spent in the trial and error for the drug formulation. The technique offers precise ability to measure the genetic variation among humans and their biological samples. Pharmaceutical companies influence this technology to fine-tune the germline genome to stabilize which, in return, enable then to buy an insurance policy during the presentation of initial findings to the FDA for the early stage approvals.

The significant reduction in the prices and rising technology is leading to the shift towards emphasizing drug development through whole-exome sequencing. Thus, owing to these factors, it is expected that the market is likely to propel expressively during the forecast period.

Some of the major primary and secondary sources included in the report for the whole exome sequencing market are World Health Organization, National Institute of Health and Medical Research, Centers for Disease Control and Prevention, The New England Journal of Medicine, among the others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Centogene AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Stratos Genomics
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Whole Exome Sequencing Market - By Product & Service
1.3.2 Global Whole Exome Sequencing Market - By Technology
1.3.3 Global Whole Exome Sequencing Market - By Application
1.3.4 Global Whole Exome Sequencing Market - By Geography

2. Global Whole Exome Sequencing Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Whole Exome Sequencing- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions

5. Global Whole Exome Sequencing Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Reduction in Time and Cost for Sequencing
5.1.2 Rising Need of Molecular Diagnosis
5.1.3 Increasing Application in Drug Discovery
5.2 Key Market Restraints
5.2.1 Ethical, Social and Legal Concerns For Whole Exome Sequencing
5.2.2 Dearth of Highly Skilled Professionals
5.3 Key Market Opportunity
5.3.1 Development of Personalized Medicine
5.4 Future Trend
5.4.1 Diagnosing and Treating Cancer Using Whole Exome Sequencing
5.5 Impact Analysis of Drivers and Restraints

6. Whole Exome Sequencing Market - Global Analysis
6.1 Global Whole Exome Sequencing Market Revenue Forecasts And Analysis
6.2 Global Whole Exome Sequencing Market, By Geography - Forecasts And Analysis
6.3 Performance Of Key Players
6.4 Positioning Of Key Players

7. Whole Exome Sequencing Market Analysis And Forecasts To 2027 - Product & Services
7.1 Overview
7.2 Global Whole Exome Sequencing Market Share by Product 2018 & 2027 (%)
7.3 Systems Market
7.3.1 Overview
7.3.2 Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Kits Market
7.4.1 Overview
7.4.2 Kits Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Services Market
7.5.1 Overview
7.5.2 Services Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3 Sequencing Services Market
7.5.3.1 Overview
7.5.3.2 Sequencing Services Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4 Data Analysis (Bioinformatics) Services Market
7.5.4.1 Overview
7.5.4.2 Data Analysis (Bioinformatics) Services Market Revenue and Forecast to 2027 (US$ Mn)
7.5.5 Others Services Market
7.5.5.1 Overview
7.5.5.2 Others Services Market Revenue and Forecast to 2027 (US$ Mn)

8. Global Whole Exome Sequencing Market Analysis to 2027 - Technology
8.1 Overview
8.2 Global Whole Exome Sequencing Market Share by Technology 2018 & 2027 (%)
8.3 Sequencing by Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Ion Semiconductor Sequencing
8.4.1 Overview
8.4.2 Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Technologies
8.5.1 Overview
8.5.2 Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Whole Exome Sequencing Market Analysis And Forecasts To 2027 - Application
9.1 Overview
9.2 Global Whole Exome Sequencing Market Share by Application 2018 & 2027 (%)
9.3 Diagnostics
9.3.1 Overview
9.3.2 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Cancer Diagnostics
9.3.3.1 Overview
9.3.3.2 Cancer Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.4 Monogenic (Mendelian) Disorders Diagnostics
9.3.4.1 Overview
9.3.4.2 Monogenic (Mendelian) Disorders Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.5 Monogenic Types of Diabetes Diagnostics
9.3.5.1 Overview
9.3.5.2 Monogenic Types of Diabetes Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6 HIV Diagnostics
9.3.6.1 Overview
9.3.6.2 HIV Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7 Others Diagnostics
9.3.7.1 Overview
9.3.7.2 Others Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Drug Discovery & Development
9.4.1 Overview
9.4.2 Drug Discovery & Development Market Revenue and Forecast To 2027 (US$ Mn)
9.5 Personalized Medicine
9.5.1 Overview
9.5.2 Personalized Medicine Market Revenue and Forecasts To 2027 (US$ Mn)
9.6 Other Application
9.6.1 Overview
9.6.2 Other Application Market Revenue and Forecasts To 2027 (US$ Mn)

10. Whole Exome Sequencing Market Revenue And Forecasts To 2027 - Regional Analysis
10.1 North America Whole Sequencing Market
10.1.1 Overview
10.1.2 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.3.1 North America Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.5 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.5.1 North America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.6 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Whole Exome Sequencing Market
10.1.7.1 US Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.7.2.1 US Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.7.3 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.7.4 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.7.4.1 US Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.8 Canada Whole Exome Sequencing Market
10.1.8.1 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.8.2.1 Canada Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.8.3 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.8.4 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.8.4.1 Canada Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.9 Mexico Whole Exome Sequencing Market
10.1.9.1 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.9.2.1 Mexico Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.9.3 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.9.4 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.9.4.1 Mexico Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2 Europe Whole Exome Sequencing Market
10.2.1 Overview
10.2.2 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.3 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.3.1 Europe Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.4 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.5 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.5.1 Europe Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.6 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.2.7 UK Whole Exome Sequencing Market
10.2.7.1 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.7.2.1 UK Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.7.3 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.7.4 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.7.4.1 UK Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.8 Germany Whole Exome Sequencing Market
10.2.8.1 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.8.2.1 Germany Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.8.3 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.8.4 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.8.4.1 Germany Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.9 France Whole Exome Sequencing Market
10.2.9.1 France Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.9.2.1 France Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.9.3 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.9.4 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.9.4.1 France Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.10 Spain Whole Exome Sequencing Market
10.2.10.1 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.2 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.10.2.1 Spain Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.10.3 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.10.4 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.10.4.1 Spain Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.11 Italy Whole Exome Sequencing Market
10.2.11.1 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.2 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.11.2.1 Italy Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.11.3 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.11.4 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.11.4.1 Italy Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3 Asia Pacific Whole Exome Sequencing Market
10.3.1 Overview
10.3.2 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.3.1 Asia Pacific Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.4 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.5 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.5.1 Asia Pacific Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.6 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Whole Exome Sequencing Market
10.3.7.1 China Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.2 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.7.2.1 China Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.7.3 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.7.4 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.7.4.1 China Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.8 Japan Whole Exome Sequencing Market
10.3.8.1 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.2 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.8.2.1 Japan Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.8.3 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.8.4 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.8.4.1 Japan Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.9 India Whole Exome Sequencing Market
10.3.9.1 India Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.2 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.9.2.1 India Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.9.3 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.9.4 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.9.4.1 India Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.10 Australia Whole Exome Sequencing Market
10.3.10.1 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.2 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.10.2.1 Australia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.10.3 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.10.4 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.10.4.1 Australia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.11 South Korea Whole Exome Sequencing Market
10.3.11.1 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.2 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.11.2.1 South Korea Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.11.3 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.11.4 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.11.4.1 South Korea Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4 Middle East & Africa Whole Exome Sequencing Market
10.4.1 Overview
10.4.2 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.3.1 Middle East & Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.4 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.5 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.5.1 Middle East & Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.6 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.4.7 UAE Whole Exome Sequencing Market
10.4.7.1 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.2 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.7.2.1 UAE Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.7.3 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.7.4 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.7.4.1 UAE Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.8 Saudi Arabia Whole Exome Sequencing Market
10.4.8.1 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.8.2.1 Saudi Arabia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.8.3 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.8.4 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.8.4.1 Saudi Arabia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.9 South Africa Whole Exome Sequencing Market
10.4.9.1 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.2 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.9.2.1 South Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.9.3 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.9.4 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.9.4.1 South Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5 South and Central America Whole Exome Sequencing Market
10.5.1 Overview
10.5.2 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.5.3.1 South and Central America Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.4 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.5.5 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.5.5.1 South and Central America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.6 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.5.7 Brazil Whole Exome Sequencing Market
10.5.7.1 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.2 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.5.7.2.1 Brazil Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.7.3 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.5.7.4 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.5.7.4.1 Brazil Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.8 Argentina Whole Exome Sequencing Market
10.5.8.1 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.2 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.5.8.2.1 Argentina Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.8.3 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.5.8.4 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.5.8.4.1 Argentina Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)

11. Whole Exome Sequencing Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Growth Strategies in the Whole Exome Sequencing Market, 2016-2019

12. Whole Exome Sequencing Market-Key Company Profiles
12.1 Stratos Genomics
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bio-Rad Laboratories, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eurofins Scientific
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Product Portfolio
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pacific Bioscience of California, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GENEWIZ
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Psomagen, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Thermo Fisher Scientific, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Illumina, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publishers
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Centogene AG
  • F. Hoffmann-La Roche AG
  • Psomagen, Inc. (previuosly Macrogen Corp.)
  • Pacific Biosciences of California, Inc.
  • Brooks Automation, Inc. (GENEWIZ, Inc.)
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • Stratos Genomics
Note: Product cover images may vary from those shown
Adroll
adroll